Is Coherus BioSciences Inc (CHRS) undervalued? · $223.7M cap
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
This page asks whether Coherus BioSciences Inc (CHRS) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued CHRS” is a slogan. Wait for the print.
CHRS currently screens at market cap $223.7M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new CHRS 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare CHRS to the stock page model before you treat a low multiple as a gift.
Not investment advice.